enVVeno Medical (NVNO) Accumulated Depreciation (2017 - 2025)

enVVeno Medical has reported Accumulated Depreciation for 9 years, with the latest figure at $1.4 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation rose 10.82% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 10.82% YoY), and the FY2025 full-year result was $1.4 million, up 10.82% from the prior year.
• Accumulated Depreciation for Q4 2025 stood at $1.4 million, up from $1.3 million in the prior quarter.
• The five-year high for Accumulated Depreciation was $1.4 million in Q4 2025, with the low at $515521.0 in Q1 2021.
• Average Accumulated Depreciation over 5 years is $938505.4, with a median of $903000.0 recorded in 2023.
• Year-over-year, Accumulated Depreciation soared 33.46% in 2022 and gained 10.82% in 2025.
• Tracing NVNO's Accumulated Depreciation over 5 years: stood at $637000.0 in 2021, then soared by 33.28% to $849000.0 in 2022, then rose by 25.91% to $1.1 million in 2023, then gained by 17.59% to $1.3 million in 2024, then climbed by 10.82% to $1.4 million in 2025.
• The last three Accumulated Depreciation figures came in at $1.4 million (Q4 2025), $1.3 million (Q1 2025), and $1.3 million (Q4 2024), per Business Quant data.

Peer Comparison